Skip to content
lifestyle.pluralist.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aspire Biopharma Holdings, Inc.
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
February 17, 2026
Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors
February 13, 2026
Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 12, 2026
←
Previous Page
1
2
3